Skip to content

Randomized Pilot Trial of AYUDA Program for Younger Latinx Adults With Type 2 Diabetes

Tailoring Initial Type 2 Diabetes Care to Meet the Needs of Younger Latinx Adults: A Randomized Pilot Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07019649
Acronym
AYUDA
Enrollment
21
Registered
2025-06-13
Start date
2025-07-25
Completion date
2026-06-09
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

The study will evaluate the feasibility, acceptability, and effectiveness of AYUDA (Assisting Younger Adults with Diabetes), a 12-week culturally text message program for Latinx adults newly diagnosed with type 2 diabetes who are caregivers to a child under 18 years old within Kaiser Permanente Northern California.

Detailed description

After designing the AYUDA program with input from the people it is meant to help, we are conducting a randomized pilot study. This study will test the program with younger Latinx adults who have recently been diagnosed with type 2 diabetes and who are also caregivers for dependent children. AYUDA is a health system specifically designed for this group, focusing on their life stage as young adults and their cultural background. The study will evaluate how well AYUDA helps participants reach important early blood sugar control goals, which can lead to better health over time and reduce complications.

Interventions

BEHAVIORALAYUDA Program

Participants randomized to the intervention arm will be enrolled in the AYUDA program, where they will receive text messages twice a week over 12 weeks containing diabetes education and self-management resources, including links to resources available to all KPNC members.

Sponsors

Kaiser Permanente
Lead SponsorOTHER
American Diabetes Association
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 44 Years
Healthy volunteers
Yes

Inclusion criteria

* KPNC member, age \>18 and age \<45 with * New clinical diagnosis of T2D within the prior 6 months * Caregiver to at least one child \<18 years of age at time of diabetes diagnosis * Identifies at Latino/a/x * Can receive text messages * Proficient (written and spoken) in English or Spanish

Exclusion criteria

* Pregnant women * Type 1 Diabetes

Design outcomes

Primary

MeasureTime frameDescription
Differences between study arms in HbA1c change 6-months following enrollment6-months following enrollmentChange in HbA1c will be assessed using HbA1c values obtained through routine care, with the most recent HbA1c preceding study enrollment and the HbA1c value closest to 6-months following enrollment used to assess HbA1c change.

Secondary

MeasureTime frameDescription
Participant-reported measures: Diabetes distressStudy enrollment and 6-months following enrollmentAssessed at study enrollment and 6-months following enrollment
Participant-reported measures: Motivation and locus of controlStudy enrollment and 6-months following enrollmentAssessed at study enrollment and 6-months following enrollment
Participant-reported measures: Care ExperienceStudy enrollment and 6-months following enrollmentAssessed at study enrollment and 6-months following enrollment
Participant-reported measures: Children's BehaviorsStudy enrollment and 6-months following enrollmentAssessed at study enrollment and 6-months following enrollment
Completion of recommended HbA1c monitoring6-months following enrollmentCompleting HbA1c labs
T2D-related medication initiation6-months following enrollmentInitiation of T2D-related medication
T2D-related medication adherence6-months following enrollmentAdherence to T2D-related medication
Use of remote glucose monitoring to measure glucose levels6-months following enrollmentUse of a remote glucose monitoring to measure glucose levels
Healthcare contact6-months following enrollmentDifferences in healthcare contact with members of the T2D diabetes care team, including care manager, PCPs, educators.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026